An updated model of hydrocephalus in sheep to evaluate the performance of a device for ambulatory wireless monitoring of cerebral pressure through shunts.


Journal

Neuro-Chirurgie
ISSN: 1773-0619
Titre abrégé: Neurochirurgie
Pays: France
ID NLM: 0401057

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 16 03 2021
revised: 16 07 2021
accepted: 04 10 2021
pubmed: 15 11 2021
medline: 6 5 2022
entrez: 14 11 2021
Statut: ppublish

Résumé

Cerebrospinal fluid (CSF) diversion by shunts is the most common surgical treatment for hydrocephalus. Though effective, shunts are associated with risk of dysfunction leading to multiple surgical revisions, affecting patient quality-of-life and incurring high healthcare costs. There is a need for ambulatory monitoring systems for life-long assessment of shunt status. The present study aimed to develop a preclinical model assessing the feasibility of our wireless device for continuous monitoring of cerebral pressure in shunts. We first adapted a previous hydrocephalus model in sheep, which used an intracisternal kaolin injection. Seven animals were used to establish the model, and 1 sheep with naturally dilated ventricles was used as control. Hydrocephalus was confirmed by clinical examination and brain imaging before inserting the ventriculoperitoneal shunts and the monitoring device allowing continuous measurement of the pressure through the shunt for a few days in 3 sheep. An external ventricular drain was used as gold standard. Our results showed that a reduction in kaolin dose associated to postoperative management was crucial to reduce morbidity and mortality rates in the model. Ventriculomegaly was confirmed by imaging 4 days after injection of 75mg kaolin into the cisterna magna. For the implanted sheep, recordings revealed high sensitivity of our sensor in detecting fluctuations in cerebral pressure compared to conventional measurements. This proof-of-concept study highlights the potential of this preclinical model for testing new shunt devices.

Sections du résumé

BACKGROUND BACKGROUND
Cerebrospinal fluid (CSF) diversion by shunts is the most common surgical treatment for hydrocephalus. Though effective, shunts are associated with risk of dysfunction leading to multiple surgical revisions, affecting patient quality-of-life and incurring high healthcare costs. There is a need for ambulatory monitoring systems for life-long assessment of shunt status. The present study aimed to develop a preclinical model assessing the feasibility of our wireless device for continuous monitoring of cerebral pressure in shunts.
METHODS METHODS
We first adapted a previous hydrocephalus model in sheep, which used an intracisternal kaolin injection. Seven animals were used to establish the model, and 1 sheep with naturally dilated ventricles was used as control. Hydrocephalus was confirmed by clinical examination and brain imaging before inserting the ventriculoperitoneal shunts and the monitoring device allowing continuous measurement of the pressure through the shunt for a few days in 3 sheep. An external ventricular drain was used as gold standard.
RESULTS RESULTS
Our results showed that a reduction in kaolin dose associated to postoperative management was crucial to reduce morbidity and mortality rates in the model. Ventriculomegaly was confirmed by imaging 4 days after injection of 75mg kaolin into the cisterna magna. For the implanted sheep, recordings revealed high sensitivity of our sensor in detecting fluctuations in cerebral pressure compared to conventional measurements.
CONCLUSIONS CONCLUSIONS
This proof-of-concept study highlights the potential of this preclinical model for testing new shunt devices.

Identifiants

pubmed: 34774581
pii: S0028-3770(21)00237-X
doi: 10.1016/j.neuchi.2021.10.006
pii:
doi:

Substances chimiques

Kaolin 24H4NWX5CO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300-308

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

M Perrotte (M)

Research and development department, Neurallys, Colombelles, Normandie, France. Electronic address: perrottemorgane@gmail.com.

J Lazardeux (J)

Research and development department, Neurallys, Colombelles, Normandie, France.

P P Sistiaga (PP)

UMS 3408, UNICAEN, CNRS, GIP Cyceron, Caen, Normandie, France.

L Chazalviel (L)

UMR6301-ISTCT, CNRS, CERVOxy Group, GIP Cyceron, Caen, Normandie, France.

R Saulnier (R)

UMS 3408, UNICAEN, CNRS, GIP Cyceron, Caen, Normandie, France.

T Metayer (T)

Department of neurosurgery, university hospital of Caen, Caen, Normandie, France; Inserm, UMR-S U1237, pathophysiology and imaging of neurological disorders, university Caen-Normandy, university hospital of Caen, GIP Cyceron, Caen, Normandie, France.

C Isnard (C)

Department of microbiology, university Caen-Normandy, UNICAEN, university hospital of Caen, Caen, Normandie, France; UNICAEN/UNIROUEN, EA2656 GRAM 2.0, university Caen-Normandy, Caen, Normandie, France.

E Emery (E)

Department of neurosurgery, university hospital of Caen, Caen, Normandie, France; Inserm, UMR-S U1237, pathophysiology and imaging of neurological disorders, university Caen-Normandy, university hospital of Caen, GIP Cyceron, Caen, Normandie, France.

P Auvray (P)

Research and development department, Neurallys, Colombelles, Normandie, France.

D Vivien (D)

Inserm, UMR-S U1237, pathophysiology and imaging of neurological disorders, university Caen-Normandy, university hospital of Caen, GIP Cyceron, Caen, Normandie, France; Department of clinical research, university hospital of Caen, Caen, Normandie, France.

T Gaberel (T)

Department of neurosurgery, university hospital of Caen, Caen, Normandie, France; Inserm, UMR-S U1237, pathophysiology and imaging of neurological disorders, university Caen-Normandy, university hospital of Caen, GIP Cyceron, Caen, Normandie, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH